North Chicago
AbbVie Advances US Expansion With $380M for Two Chicago Plants
Biopharmaceutical giant AbbVie will invest $380 million to build two new manufacturing facilities at its Illinois campus, expanding its domestic… Read more
AbbVie Sets $195M Expansion of North Chicago Manufacturing Plant
AbbVie will invest $195 million in its North Chicago, IL manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the… Read more
Jelly Belly to Close North Chicago Plant
The Jelly Belly plant in North Chicago is set to close in October, with the parent company, Ferrara Candy, planning… Read more
Chicago, Midwest | Weekly People & Companies for March 15, 2024
Kiser Group has announced the newest member of its team, Yun Park. With over 30 years of extensive experience in… Read more
Drugmaker AbbVie to Buy Cancer Biotech ImmunoGen for $10B
North Chicago-based AbbVie, a major biopharmaceutical company, will buy ImmunoGen, a biotechnology firm, for $10.1 billion in cash, as the drugmaker… Read more
Red Oak Provides Refi on North Chicago Industrial
Red Oak Capital Holdings, a Grand Rapids, MI-based commercial real estate finance company, has provided $3.25 million to refinance and renovate a… Read more
CenterPoint Sells Eight-Property Industrial Portfolio to EQT Exeter
JLL Capital Markets closed the sale of an eight-property, Class A industrial portfolio totaling 3,825,589 square feet of existing assets… Read more
Baum Realty Completes 20 Retail Leases
Baum Realty Group wrapped up the third quarter with 20 closed retail transactions across the Chicago area. On the tenant side, Baum represented: … Read more
CRE and Employment Impact of AbbVie/Allergan Deal is Unclear
The economic and real estate implications of North Chicago, IL-based AbbVie’s $63-billion acquisition of rival drugmaker Allergan aren’t yet clear.… Read more